Evidence map›Paper›PMID 23947399›Full record

ArticleJournal of biomedical science2013

Substantial increase in the frequency of circulating CD4+NKG2D+ T cells in patients with cervical intraepithelial neoplasia grade 1.

Mariel Garcia-Chagollan, Luis F Jave-Suarez, Jesse Haramati, Pedro E Sanchez-Hernandez, Adriana Aguilar-Lemarroy, Miriam R Bueno-Topete, Ana L Pereira-Suarez, Mary Fafutis-Morris, Angel Cid-Arregui, Susana del Toro-Arreola

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Novel and potent MICA/B antibody is therapeutically effective inJournal for immunotherapy of cancer · 2025
    Article
  3. Functions of Traditional Chinese Medicine Combined with Recombinant Human InterferonEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  4. Regulatory NK1.1Cancer immunology, immunotherapy : CII · 2018
    Article
  5. Review
  6. Review
  7. NK1.1Journal of cellular and molecular medicine · 2017
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Mariel Garcia-ChagollanLaboratorio de Inmunología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada # 950, Colonia Independencia, Guadalajara, Jalisco CP 44340, México.
Luis F Jave-Suarez
Jesse Haramati
Pedro E Sanchez-Hernandez
Adriana Aguilar-Lemarroy
Miriam R Bueno-Topete
Ana L Pereira-Suarez
Mary Fafutis-Morris
Angel Cid-Arregui
Susana del Toro-Arreola
Universidad de Guadalajara · MXMexican Social Security Institute · MXGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe NKG2D receptor confers important activating signals to NK cells via ligands expressed during cellular stress and viral infection. This receptor has generated great interest because not only is it expressed on NK cells, but it is also seen in virtually all CD8+ cytotoxic T cells and is classically considered absent in CD4+ T cells. However, recent studies have identified a distinctive population of CD4+ T cells that do express NKG2D, which could represent a particular cytotoxic effector population involved in viral infections and chronic diseases. On the other hand, increased incidence of human papillomavirus-associated lesions in CD4+ T cell-immunocompromised individuals suggests that CD4+ T cells play a key role in controlling the viral infection. Therefore, this study was focused on identifying the frequency of NKG2D-expressing CD4+ T cells in patients with cervical intraepithelial neoplasia (CIN) 1. Additionally, factors influencing CD4+NKG2D+ T cell expansion were also measured.

resultsClose to 50% of patients with CIN 1 contained at least one of the 37 HPV types detected by our genotyping system. A tendency for increased CD4+ T cells and CD8+ T cells and decreased NK cells was found in CIN 1 patients. The percentage of circulating CD4+ T cells co-expressing the NKG2D receptor significantly increased in women with CIN 1 versus control group. Interestingly, the increase of CD4+NKG2D+ T cells was seen in patients with CIN 1, despite the overall levels of CD4+ T cells did not significantly increase. We also found a significant increase of soluble MICB in CIN 1 patients; however, no correlation with the presence of CD4+NKG2D+ T cells was seen. While TGF-beta was significantly decreased in the group of CIN 1 patients, both TNF-alpha and IL-15 showed a tendency to increase in this group.

conclusionsTaken together, our results suggest that the significant increase within the CD4+NKG2D+ T cell population in CIN 1 patients might be the result of a chronic exposure to viral and/or pro-inflammatory factors, and concomitantly might also influence the clearance of CIN 1-type lesion.

Indexed as

AdultCD4-Positive T-LymphocytesFemaleHistocompatibility Antigens Class IHumansKiller Cells, NaturalMiddle AgedNeoplasm GradingNeoplastic Cells, CirculatingNK Cell Lectin-Like Receptor Subfamily KPapillomaviridaeTumor Necrosis Factor-alphaUterine Cervical DysplasiaHistocompatibility Antigens Class IKLRK1 protein, humanMHC class I-related chain ANK Cell Lectin-Like Receptor Subfamily KTumor Necrosis Factor-alpha

Identifiers

PMID23947399
PMCPMC3751941
OpenAlexW2114956653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.